Catatan Ja'far Tamam

Indonesia is working to produce its own COVID-19 vaccine next year, amid growing anxiety that developing countries could have difficulty getting access to a future jab, the head of Indonesia’s national COVID-19 research team said Thursday.

 Kepala tim peneliti Covid19 mengatakan pada Kamis lalu bahwa Indonesia tengah berupaya memproduksi vaksin Covid19 pada tahun mendatang, hal ini di tengah tumbuhnya kegelisahan di kalangan negara berkembang yang kesulitan mendapatkan akses pendapatan vaksin tersebut.

“The production capability and capacity of biotech companies in the world is, we know, limited, and global supply chains also have challenges,” Ali Ghufron Mukti, head of the innovation team at Indonesia’s research and technology ministry, told a streamed press conference alongside the country’s foreign minister.

""Kemampuan dan kesediaan yang dilakukan oleh komunitas biotek di dunia, kita tahu, terbatas dan penyuplaian global juga tengah mendapat tantangan," ucap Ali Ghufron Mukti, kepala tim inovasi di kementerian Teknologi dan Penelitian, saat konferensi pers.

“Therefore, it is necessary for Indonesia to develop its own COVID-19 vaccine. And it will be by Indonesia, from Indonesia, to Indonesia,” he said.

"Dari sana,Indonesia perlu untuk untuk mengadakan vaksin Covid19. Dan ini menjadi produk Indonesia yang diperuntukkan bagi bangsa Indonesia." Ujarnya.

"We are using our theory and we are optimistic that in the year 2021 and early 2021, this will be finished in the laboratory," he said, adding state-owned firm Bio Farma could conduct trials in the second half of next year.

"Kita menggunakan teori kita dan sikap optimis untuk mewujudkan pada tahun 2021, hal ini akan diselesaikan di laboratorium," ujarnya menambahi upaya percobaan pembuatan Vaksin pada semester kedua tahun depan yang dilakukan Biofarma.

Indonesia’s Foreign Minister Retno Marsudi has in recent months spoken about the need for developing countries to have access to any future vaccine, amid concern that rich countries would try to corner a limited supply.

Such concerns increased this week, when the United States announced it had bought up most of the global supply of Gilead Sciences Inc.'s drug remdesivir, shown to speed up recovery times from COVID-19.

Keprihatinan tersebut meningkat minggu ini saat Amerika mengumumkan telah membeli suplai global dari Gilead Scienc.ind  sebagai upaya mempercepat penyembuhan Covid19.

The pandemic has sparked a race to find a vaccine, with more than 100 in development and around a dozen already being tested in humans.

Pandemi memicu upaya untuk mencari vaksin dengan lebih dari 100 pengembangan dan sekitar puluhan upaya tes kepada manusia yang siap dilancarkan.

On Thursday, Mukti also outlined efforts underway between local and foreign pharmaecutical companies to mass produce a vaccine in Indonesia. A COVID-19 Vaccine Development Team has been tasked with guaranteeing the availability of a vaccine nationally within the next 12 months.

Pada Kamis, Mukti memetakan upaya antara pihak lokal dan farmasi asing untuk memproduksi vaksin di Indonesia. Tim Pengembangan Vaksin Covid19 telah bekerja dan menjamin upaya penyediaan vaksin secara nasional dalam 12 bulan ke depan.

Honesti Basyir, the director of Bio Farma, told Reuters in late June it was working with Chinese firm Sinovac on a vaccine which would enter the third phase of clinical trials in humans this month. If the trial is successful, it could start production in the first quarter of next year with a minimum 100 million doses.

Honesti Basyir, direktor Bio Farma, mengatakan bahwa Juni lalu telah bekerjasama dengan perisahan China Sinovac dalam hal pengadaan vaksin, dan sudah memasuki tahap ketika percobaan kepada manusia. Jika percobaan ini berhasil, mereka akan memulai produksi pada quartal pertama tahun depan dengan minimum pembuatan 100 juta vaksin.

With a population of more than 265 million, Indonesia estimates it would need more than 352 million shots of a two-dose vaccine.

]Dengan populasi lebih dari 265 juta, Indonesia mengestimasikan butuh lebih dari 352 juta vaksin

On Thursday Indonesia recorded 1,624 new coronavirus cases, the highest daily rise so far, taking the total numbers of cases to 59,394.

Pada Kamis lalu, Indonesia mencatata ada 1.624 kasus baru, capaian harian tertinggi. Hal ini membawa total kasus di Indonesia menjadi 59.394 kasus.

In addition to Bio Farma and Sinovac, Mukti said private Indonesian pharmaceutical firm Kalbe Farma and the South Korean biotech company Genexine were cooperating to produce a vaccine.

Menambahi komentar atas kerjasama Bio Farma dan Sinovac, Mukti mengatakan bahwa Farmasi Indonesia Kalbe Farma dan Biotext Korea Utara tengah bekerjasama pula secara rahasia dalam memproduksi vaksin.

Source : https://www.thejakartapost.com/news/2020/07/03/indonesia-seeking-its-own-covid-19-vaccine-amid-worry-about-access.html?utm_campaign=os&utm_source=mobile&utm_medium=android